rs142075710
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001364905.1(LRBA):c.3262G>C(p.Glu1088Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000297 in 1,613,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001364905.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRBA | NM_001364905.1 | c.3262G>C | p.Glu1088Gln | missense_variant | Exon 23 of 57 | ENST00000651943.2 | NP_001351834.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRBA | ENST00000651943.2 | c.3262G>C | p.Glu1088Gln | missense_variant | Exon 23 of 57 | NM_001364905.1 | ENSP00000498582.2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000175 AC: 44AN: 250722Hom.: 0 AF XY: 0.000170 AC XY: 23AN XY: 135594
GnomAD4 exome AF: 0.000307 AC: 448AN: 1461248Hom.: 0 Cov.: 32 AF XY: 0.000299 AC XY: 217AN XY: 726960
GnomAD4 genome AF: 0.000210 AC: 32AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74364
ClinVar
Submissions by phenotype
Combined immunodeficiency due to LRBA deficiency Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 1088 of the LRBA protein (p.Glu1088Gln). This variant is present in population databases (rs142075710, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with LRBA-related conditions. ClinVar contains an entry for this variant (Variation ID: 566454). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LRBA protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.3262G>C (p.E1088Q) alteration is located in exon 23 (coding exon 22) of the LRBA gene. This alteration results from a G to C substitution at nucleotide position 3262, causing the glutamic acid (E) at amino acid position 1088 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
The p.Glu1088Gln variant (rs142075710) has not been reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the Genome Aggregation Database (gnomAD) with an overall population frequency of 0.04 percent (identified on 50 out of 276,512 chromosomes). The glutamic acid at position 1088 is weakly conserved considering 13 species (Alamut v2.10) and computational analyses of the effects of the p.Glu1088Gln variant on protein structure and function provide conflicting results (SIFT: tolerated, MutationTaster: disease causing, PolyPhen-2: benign). Altogether, there is not enough evidence to classify the p.Glu1088Gln variant with certainty. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at